Enbridge Inc
ENB
Choice Properties Real Estate Investment Trust
CHP.UN
Brookfield Renewable Partners LP
BEP.UN
The Toronto-Dominion Bank
TD
TC Energy Corp
TRP
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 3.000
- -0.130-4.15%
15min DelayMarket Closed Dec 20 16:00 ET
210.92MMarket Cap-7.89P/E (TTM)
3.100High2.770Low105.52KVolume3.100Open3.130Pre Close310.82KTurnover3.98052wk High0.18%Turnover Ratio70.31MShares1.65052wk Low-0.38EPS TTM174.98MFloat Cap3.980Historical HighLossP/E (Static)58.33MShs Float0.800Historical Low-0.38EPS LYR10.54%Amplitude--Dividend TTM22.90P/B1Lot Size--Div YieldTTM
NervGen Pharma Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -302.52%-5.75M | -109.18%-4.18M | 32.09%-3.25M | 36.49%-11.3M | 38.93%-3.09M | 70.28%-1.43M | 45.90%-2M | -13.11%-4.78M | -115.07%-17.78M | -76.92%-5.05M |
| Net income from continuing operations | -21.46%-5.23M | -64.34%-7.83M | 50.19%-2.35M | -8.01%-22.38M | -44.92%-8.61M | -23.07%-4.3M | 24.63%-4.76M | 5.20%-4.71M | -62.83%-20.72M | -43.25%-5.94M |
| Operating gains losses | -263.26%-1.67M | 1,201.29%1.86M | -1,483.48%-2.27M | 297.34%5.12M | 628.50%3.79M | 153.44%1.02M | 285.75%142.6K | 4,273.79%164.03K | -8,172.95%-2.6M | -1,480.34%-718.02K |
| Depreciation and amortization | -60.00%14.65K | -57.06%15.03K | 10.22%38.31K | 25.96%145K | 11.13%38.62K | 5.39%36.63K | 2.27%35K | 205.29%34.75K | 170.06%115.11K | 210.14%34.75K |
| Remuneration paid in stock | -7.57%1.62M | -37.49%1.35M | 56.28%1.15M | 117.83%6.04M | 159.18%1.39M | 187.55%1.75M | 160.24%2.16M | -7.57%736.78K | -30.90%2.77M | -50.10%537.12K |
| Other non cashItems | -99.97%1 | 81.35%6.94K | -31.37%2.85K | -97.23%14.66K | -28.72%3.18K | -99.32%3.51K | --3.83K | --4.15K | --528.9K | --4.46K |
| Change In working capital | -936.03%-495.15K | -0.84%415.56K | 117.27%174.85K | -111.36%-240.35K | -71.45%293.54K | 110.47%59.23K | -75.59%419.1K | -1,473.59%-1.01M | 391.28%2.11M | 581.31%1.03M |
| -Change in receivables | -69.54%5.11K | -95.95%2.03K | 474.63%236.63K | -703.60%-223.18K | -43,531.54%-226.88K | -76.13%16.78K | 285.95%50.08K | -975.86%-63.16K | 2,726.07%36.98K | 97.64%-520 |
| -Change in prepaid assets | -3.29%-164.92K | 136.12%121.77K | -145.94%-170.85K | 123.65%57.32K | 166.31%182.21K | -407.73%-159.67K | -519.63%-337.15K | 472.82%371.94K | -314.12%-242.33K | -259.54%-274.8K |
| -Change in payables and accrued expense | -265.92%-335.34K | -58.68%291.77K | 108.26%109.07K | -103.21%-74.49K | -74.05%338.21K | 129.39%202.12K | -57.54%706.17K | -3,297.88%-1.32M | 627.98%2.32M | 186,121.57%1.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -302.52%-5.75M | -109.18%-4.18M | 32.09%-3.25M | 36.49%-11.3M | 38.93%-3.09M | 70.28%-1.43M | 45.90%-2M | -13.11%-4.78M | -115.07%-17.78M | -76.92%-5.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 118.22%25.23K | 385.70%8.41K | 0 | -557.92%-138.85K | 1 | -2,320.19%-138.46K | 70.54%-2.94K | 147.27%2.55K | 53.19%-21.11K | 0 |
| Net PPE purchase and sale | --0 | --0 | --0 | 85.43%-3.07K | --1 | 53.17%-2.68K | 70.54%-2.94K | 147.27%2.55K | -667.73%-21.11K | --0 |
| Net intangibles purchas and sale | --25.23K | ---- | ---- | ---135.78K | --0 | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 118.22%25.23K | 385.70%8.41K | --0 | -557.92%-138.85K | --1 | -2,320.19%-138.46K | 70.54%-2.94K | 147.27%2.55K | 53.19%-21.11K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 272.66%269.74K | -56.17%111.28K | 5,924.01%22M | -96.62%766.29K | -6.16%74.77K | -99.64%72.38K | -90.09%253.86K | 184.63%365.27K | 15.44%22.64M | -99.31%79.68K |
| Net issuance payments of debt | 0.00%-25.23K | 0.00%-25.23K | 0.00%-25.23K | -33.33%-100.93K | 0.00%-25.23K | -0.00%-25.23K | 0.00%-25.23K | ---25.23K | ---75.7K | ---25.23K |
| Net common stock issuance | --0 | --0 | --23.01M | --0 | --0 | --0 | --0 | --0 | 4.56%19.76M | -99.06%108.35K |
| Proceeds from stock option exercised by employees | 202.16%294.95K | -41.26%163.95K | 58.89%620.46K | -71.87%867.21K | -20.38%100K | -58.51%97.61K | -89.24%279.09K | 204.29%390.51K | 29.67%3.08M | -87.89%125.6K |
| Net other financing activities | --19 | ---27.44K | ---1.6M | ---- | ---- | ---- | ---- | ---- | 92.26%-129.04K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 272.66%269.74K | -56.17%111.28K | 5,924.01%22M | -96.62%766.29K | -6.16%74.77K | -99.64%72.38K | -90.09%253.86K | 184.63%365.27K | 15.44%22.64M | -99.31%79.68K |
| Net cash flow | ||||||||||
| Beginning cash position | 65.15%26.56M | 68.15%30.3M | -48.07%11.66M | 32.62%22.45M | -46.62%14.79M | 38.06%16.08M | 40.48%18.02M | 32.62%22.45M | 202.38%16.93M | 235.78%27.7M |
| Current changes in cash | -265.01%-5.46M | -132.37%-4.06M | 524.97%18.76M | -320.59%-10.67M | 39.46%-3.01M | -109.93%-1.5M | -53.06%-1.75M | -7.54%-4.41M | -57.20%4.84M | -156.97%-4.97M |
| Effect of exchange rate changes | -147.23%-93.56K | 266.02%317.11K | -585.85%-112.37K | -118.04%-123.89K | 58.18%-114.58K | -80.06%198.07K | -416.69%-191K | -516.90%-16.38K | 2,088.15%686.58K | -426.66%-273.95K |
| End cash Position | 42.09%21.01M | 65.15%26.56M | 68.15%30.3M | -48.07%11.66M | -48.07%11.66M | -46.62%14.79M | 38.06%16.08M | 40.48%18.02M | 32.62%22.45M | 32.62%22.45M |
| Free cash from | -266.97%-5.75M | -108.88%-4.18M | 32.09%-3.25M | 35.77%-11.44M | 38.93%-3.09M | 67.44%-1.57M | 45.97%-2M | -12.97%-4.78M | -114.15%-17.81M | -76.92%-5.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.